These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6226963)

  • 21. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butriptyline hydrochloride and imipramine hydrochloride in the treatment of non-psychotic depression. A double-blind trial.
    Levinson B
    S Afr Med J; 1974 Apr; 48(20):873-5. PubMed ID: 4597908
    [No Abstract]   [Full Text] [Related]  

  • 23. The beneficial effects of amineptine (Survector 100) in the treatment of depression: preliminary results of an Indian multicenter trial.
    Boral GC; Shah LP
    Clin Neuropharmacol; 1989; 12 Suppl 2():S51-7. PubMed ID: 2698271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G; Garreau M; Orofiamma B; Palminteri R
    Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression in elderly people treated with amineptine (Survector 100): a synopsis.
    Marconi PL; Brugnoli R; Bressa GM
    Clin Neuropharmacol; 1989; 12 Suppl 2():S97-105. PubMed ID: 2698275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW; van Hulst AM; van der Mast RC; van de Wetering BJ
    Psychopharmacology (Berl); 1996 Oct; 127(3):231-7. PubMed ID: 8912401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs)].
    Beresewicz M; Bidzińska E; Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):13-8. PubMed ID: 1687987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
    Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?
    Volz HP; Müller H; Möller HJ
    Neuropsychobiology; 1995; 32(1):23-30. PubMed ID: 7566519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
    Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
    Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amineptine: clinical considerations on a new antidepressive].
    Carreca A; Caserta F; Ingrassia MA; La Rosa F; Lo Baido R; Nastri L
    Clin Ter; 1985 Dec; 115(6):449-52. PubMed ID: 3830544
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J; Tamminen T; Elosuo R; Manniche PM
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
    Ferreri M
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():97-101. PubMed ID: 2644344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].
    Dalery J; Rochat C; Peyron E; Bernard G
    Encephale; 1992; 18(3):257-62. PubMed ID: 1299597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.